Speaker Profile
Ph.D., CTO, Dxcover Ltd
Biography
Dr Baker is the inventor of the Dxcover Liquid Biopsy suite and is responsible for the technical and scientific strategy and direction of the company. He was awarded a prestigious fellowship straight after PhD to work at the Robert Koch Institute and Harvard Medical School. He followed this with periods at the Ministry of Defence and several academic institutions. He is a global leader in clinical spectroscopy who has been awarded Top 6 Best British Tech Pioneers (2020), Fellow of the Society of Applied Spectroscopy (2020), Top 40 under 40 analytical scientists (2018), RSC Harrison Meldola Memorial Prize (2017) and the Emerging Leader in Molecular Spectroscopy (2016) amongst others. He is committed to the translation of his inventions from the bench to the bedside for the benefit of patients and global health.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Victor Velculescu, Johns Hopkins
PMWC Award Ceremony
• Klaus Pantel, UKE & ELBS
• Daniel De Carvalho, University of Toronto
Keynote
• Klaus Pantel, UKE & ELBS
From Mutation to Methylation: The Next Wave of Liquid Biopsy Biomarkers
• Chair: Victor Velculescu, Johns Hopkins
• Daniel De Carvalho, University of Toronto
• Manel Esteller, Sant Pau Research Institute
Advancing Minimal Residual Disease (MRD) Detection through cfDNA and cfRNA Profiling
• Chair: Luis Diaz, MSKCC
• Anne-Renee Hartman, Adela
• Klaus Pantel, UKE & ELBS
AI-Informed Biomarker Trials: Turning Early Detection Signals into Clinically Actionable Designs
• Chair: Manish Kohli, University of Utah
• Luis Diaz, MSKCC
• Amoolya Singh, DELFI Diagnostics
• Peter Bach, DELFI Diagnostics
Fragmentomics for Early Detection: End Motifs and Library Prep
• Varsha Rao, Claret Bioscience
Integrating Genetic Risk with Early Detection: A Precision Prevention Framework for Cardiovascular Disease
• Giordano Botta, Allelica
Role of AI in Liquid Biopsies and Cancer Detection
• Chair: Amoolya Singh, DELFI Diagnostics
• Matthew Baker, Dxcover
